Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients

JOURNAL ARTICLE published 1 July 2022 in JAMA Oncology

Authors: Kelly M. Kenzik | P. Connor Johnson | Ravi Bhatia | Smita Bhatia

Comparison of Therapy in Advanced Hepatocellular Carcinoma Based on Clear Definition and Accurate Subgroup Data

JOURNAL ARTICLE published 1 June 2021 in JAMA Oncology

Authors: Fucun Xie | Jinzhu Mao | Haitao Zhao

Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine

JOURNAL ARTICLE published 1 November 2018 in JAMA Oncology

Authors: Megan C. Roberts

Metformin—A Thought-provoking Addition to Anticancer Therapies

JOURNAL ARTICLE published 1 February 2022 in JAMA Oncology

Authors: Jiaqi Liang | Cheng Zhan | Qun Wang

Error in Funding/Support

JOURNAL ARTICLE published 1 July 2021 in JAMA Oncology

Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms

JOURNAL ARTICLE published 1 May 2018 in JAMA Oncology

Authors: Emmanuelle Zamparini | Ida Pavese | François Vincent

JAMA Oncology

JOURNAL ARTICLE published 1 July 2019 in JAMA Oncology

Lower Back Pain in a Patient With Sarcoma

JOURNAL ARTICLE published 1 June 2021 in JAMA Oncology

Authors: Sebastian Mönch | Gabriel Scheubeck | Wolfgang G. Kunz

Error in Coauthor’s Name

JOURNAL ARTICLE published 1 November 2020 in JAMA Oncology

Tissue-Based PD-L1 Expression Is the Strongest Predictor of Overall Survival Benefit From ICI in Advanced Gastroesophageal Cancer—Reply

JOURNAL ARTICLE published 1 February 2023 in JAMA Oncology

Authors: Harry H. Yoon | Qian Shi | Jaffer A. Ajani

The Multidisciplinary Cancer Conference

JOURNAL ARTICLE published 1 February 2023 in JAMA Oncology

Authors: Eric K. Singhi | Jill Feldman | Howard (Jack) West

High-risk Human Papillomavirus Testing for Cervical Cancer Screening—Reply

JOURNAL ARTICLE published 1 July 2021 in JAMA Oncology

Authors: Le Dang | Youlin Qiao | Jinghe Lang

Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib

JOURNAL ARTICLE published 1 June 2018 in JAMA Oncology

Authors: Scott M. Schuetze | Vanessa Bolejack | Dafydd G. Thomas | Margaret von Mehren | Shreyaskumar Patel | Brian Samuels | Edwin Choy | Gina D’Amato | Arthur P. Staddon | Kristen N. Ganjoo | Warren A. Chow | Daniel A. Rushing | Charles A. Forscher | Dennis A. Priebat | David M. Loeb | Rashmi Chugh | Scott Okuno | Denise K. Reinke | Laurence H. Baker

Aiming for the Cure in ERBB2-Positive Metastatic Breast Cancer—Should We Go “All In”?

JOURNAL ARTICLE published 1 August 2022 in JAMA Oncology

Authors: Bruno Henrique Rala de Paula | Susanne Crocamo

Errors in Byline and Affiliations

JOURNAL ARTICLE published 1 July 2022 in JAMA Oncology

Errors in Byline

JOURNAL ARTICLE published 1 July 2022 in JAMA Oncology

Evidence Base on the Potential Carcinogenicity of Radiofrequency Radiation

JOURNAL ARTICLE published 1 June 2022 in JAMA Oncology

Authors: David O. Carpenter | Lennart Hardell | Cindy Sage

Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer—Reply

JOURNAL ARTICLE published 1 April 2022 in JAMA Oncology

Authors: Daneng Li | Mina S. Sedrak | William Dale

PSMA PET in Prostate Cancer—A Biomarker or a Surrogate End Point?—Reply

JOURNAL ARTICLE published 1 April 2022 in JAMA Oncology

Authors: Thomas A. Hope | Jeremie Calais

Immune-Related Adverse Events—A Novel Prediction of Nivolumab Efficacy?

JOURNAL ARTICLE published 1 July 2018 in JAMA Oncology

Authors: Yanlei Cheng | Yaogui Wu | Long Wu